Broadwater Capital Management LLC Bio Techne Corp Transaction History
Broadwater Capital Management LLC
- $137 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding TECH
# of Institutions
617Shares Held
161MCall Options Held
225KPut Options Held
80.8K-
Vanguard Group Inc Valley Forge, PA18.4MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$938 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.85MShares$554 Million0.05% of portfolio
-
Morgan Stanley New York, NY6.58MShares$412 Million0.02% of portfolio
-
State Street Corp Boston, MA5.86MShares$367 Million0.01% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.45B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...